The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Specificity of Serotonin Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder: Comparison of Fluvoxamine and Desipramine
Abstract
To evaluate whether serotonin reuptake inhibition is critical to the treatment of obsessive-compulsive disorder, 40 outpatients with a principal diagnosis of obsessive-compulsive disorder were randomized in a double-blind fashion to 8 weeks of treatment with either the serotonin reuptake inhibitor fluvoxamine maleate (n = 21) or the norepinephrine reuptake inhibitor desipramine hydrochloride (n = 19). Fluvoxamine was significantly better than desipramine in reducing the severity of obsessive-compulsive symptoms, as measured by the Yale-Brown Obsessive Compulsive Scale and by the global response rate ("responder" equaling "much improved"). Eleven of 21 patients were responders with fluvoxamine compared with 2 of 19 patients with desipramine. Fluvoxamine, but not desipramine, was also effective in reducing the severity of "secondary" depression. Fluvoxamine-induced improvement in symptoms of obsessive-compulsive disorder was not correlated with the severity of baseline depressive symptoms. This study provides additional evidence that the acute serotonin reuptake properties of a drug are predictive of its anti-obsessive-compulsive efficacy. It is hypothesized that the mechanism of action of serotonin reuptake inhibitors in obsessive-compulsive disorder may be related to chronic treatment-induced adaptive changes in presynaptic serotonin receptor function (eg, autoreceptor desensitization) and/or indirect influences on dopaminergic function (eg, in the basal ganglia).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Self-citationThe Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
Self-citationLifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
The Epidemiology of Obsessive-Compulsive Disorder in Five US Communities
Karno, M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360042006 · Cited by 1,351
Baxter, L. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150017003 · Cited by 860
Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka, S. J., & Snyder, S. H. (1980) · Science · doi:10.1126/science.6251550 · Cited by 832
Charney, D. S. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780350094011 · Cited by 649
Pauls, D. L. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800120066013 · Cited by 575
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
Schmidt, C. J. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22673-8 · Cited by 529
Clomipramine Treatment of Obsessive-Compulsive Disorder: I. A Controlled Clinical Trial
Thorén, P. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780240079009 · Cited by 497
Benfield, P., & Ward, A. (1986) · Drugs · doi:10.2165/00003495-198632040-00002 · Cited by 494
Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament, M. F. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330057007 · Cited by 466
Clomipramine and Exposure for Obsessive-Compulsive Rituals: 1
Marks, I. M., Stern, R. S., Mawson, D., Cobb, J., & McDonald, R. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.1.1 · Cited by 448
(1989) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.1.1.27 · Cited by 425
High prevalence of obsessive–compulsive symptoms in patients with Sydenham's chorea
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.2.246 · Cited by 421
Zohar, J., & Insel, T. R. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90199-5 · Cited by 416
BLIER, P., de MONTIGNY, C., & CHAPUT, Y. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00003 · Cited by 404
Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder: A Double-blind Comparison With Placebo
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010038006 · Cited by 390
Self-citationCerebral glucose metabolic rates in obsessive compulsive disorder
NORDAHL, T. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90003-1 · Cited by 383
Hervé, D., Pickel, V. M., Joh, T. H., & Beaudet, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91588-5 · Cited by 372
Serotonergic Neuronal Systems: What Their Anatomic Organization Tells Us about Function
MOLLIVER, M. E. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00002 · Cited by 347
Obsessive-compulsive disorder and serotonin: Is there a connection?
Insel, T. R., Mueller, E. A., Alterman, I., Linnoila, M., & Murphy, D. L. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90176-3 · Cited by 343
Chaput, Y., de Montigny, C., & Blier, P. (1986) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00500007 · Cited by 323
Hudak, R., & Gannon, J. M. (2022) · Current Clinical Practice · doi:10.1007/978-3-030-98709-1_5 · Cited by 306
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.8.1030 · Cited by 301
Zohar, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260081011 · Cited by 294
The Gilles de la Tourette Syndrome: the Current Status
Robertson, M. M. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.2.147 · Cited by 289
DEN BOER, J. A., & WESTENBERG, H. G. M. (1988) · International Clinical Psychopharmacology · doi:10.1097/00004850-198801000-00005 · Cited by 288
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.9.1089 · Cited by 284
Clomipramine in obsessive-compulsive disorder
Katz, R. J., DeVeaugh-Geiss, J., & Landau, P. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90408-t · Cited by 245
The epidemiology of obsessive compulsive disorder.
Rasmussen, S. A., & Tsuang, M. T. (1984) · PubMed · Cited by 222
Clinical comparison of Tourette's disorder and obsessive-compulsive disorder
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.9.1166 · Cited by 218
Fluvoxamine treatment of obsessive-compulsive disorder
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.12.1543 · Cited by 214
Obsessive-compulsive disorder: evidence for basal ganglia dysfunction.
Jl, R., & Sp, W. (1988) · PubMed · Cited by 176
Fluoxetine Treatment of Obsessive-Compulsive Disorder
TURNER, S. M., JACOB, R. G., BEIDEL, D. C., & HIMMELHOCH, J. (1985) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198508000-00003 · Cited by 167
Hyttel, J., Over�, K. F., & Arnt, J. (1984) · Psychopharmacology · doi:10.1007/bf00427416 · Cited by 164
Blier, P., & de Montigny, C. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90107-1 · Cited by 151
Benkelfat, C., Murphy, D. L., Zohar, J., Hill, J. L., Grover, G. N., & Insel, T. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010025004 · Cited by 150
Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis
Ananth, J., Pecknold, J. C., Steen, N. V. D., & Engelsmann, F. F. (1981) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(81)90077-1 · Cited by 150
Behavioral aspects of serotonin-dopamine interaction in the monkey
Korsgaard, S., Gerlach, J., & Christensson, E. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90135-9 · Cited by 146
Chronic, Multiple Tics of Gilles de la Tourette's Disease
Cohen, D. J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770260123015 · Cited by 146
Adolfsson, R., Gottfries, C. G., Nyström, L., & Winblad, B. G. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00670.x · Cited by 143
Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression
Träskman, L., Åsberg, M., Bertiisson, L., Cronholm, B., Mellström, B., Neckers, L. Μ., Sjöqvist, F., Thorén, P., & Tybring, G. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979265600 · Cited by 142
Characterization and regional distribution of serotonin S2-receptors in human brain
Schotte, A., Maloteaux, J. M., & Laduron, P. M. (1983) · Brain Research · doi:10.1016/0006-8993(83)90729-1 · Cited by 133
Stolz, J. F., Marsden, C. A., & Middlemiss, D. N. (1983) · Psychopharmacology · doi:10.1007/bf00427959 · Cited by 125
Clomipramine and imipramine in obsessive-compulsive disorder
Volavka, J., Neziroglu, F. A., & Yaryura-Tobias, J. A. (1985) · Psychiatry Research · doi:10.1016/0165-1781(85)90092-7 · Cited by 124
Treatment of severe obsessive-compulsive disorder with fluvoxamine
Price, L. H., Goodman, W. K., Charney, D. S., Rasmussen, S. A., & Heninger, G. R. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.8.1059 · Cited by 118
Self-citationPotter, W. Z. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790350045009 · Cited by 118
Animal models of compulsive behavior
Pitman, R. K. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90022-x · Cited by 117
Mavissakalian, M., Turner, S. M., Michelson, L. K., & Jacob, R. G. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.5.572 · Cited by 115
RAKIC, P. T., RAKIC, P. T., & Gallager, D. W. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-10-03670.1988 · Cited by 107
Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography
Waeber, C., Dietl, M. M., Hoyer, D., Probst, A., & Palacios, J. M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90307-2 · Cited by 105
Detection and Characterization of the Serotonin 5‐HT1D Receptor in Rat and Human Brain
Herrick‐Davis, K., & Titeler, M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb03052.x · Cited by 104
Treatment of Obsessive Compulsive Disorder with Clomipramine
DeVeaugh-Geiss, J., Landau, P., & Katz, R. J. (1989) · Psychiatric Annals · doi:10.3928/0048-5713-19890201-11 · Cited by 103
Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences
Simoni, M. G. D., Toso, G. D., Fodritto, F., Sokoła, A., & Algeri, S. (1987) · Brain Research · doi:10.1016/0006-8993(87)90683-4 · Cited by 95
Leonard, H., Swedo, S. E., Rapoport, J. L., Coffey, M., & Cheslow, D. L. (1988) · PubMed · Cited by 94
Recent Advances in the Behavioral Treatment of Obsessive-Compulsives
Steketee, G. S. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290120001001 · Cited by 86
Serotonin Reuptake Blockers in Vitro and in Vivo
Fuller, R. W., & WONG, D. T. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00004 · Cited by 85
Price, L., Charney, D., Delgado, P., Anderson, G., & Heninger, G. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810070051009 · Cited by 80
Clomipramine Treatment of Agoraphobic Women: An Eight-Week Controlled Trial
Johnston, D. G., Troyer, I. E., & Whitsett, S. F. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290073009 · Cited by 77
Fluoxetine in the Long-Term Maintenance Treatment of Obsessive Compulsive Disorder
Fontaine, R., & Chouinard, G. (1989) · Psychiatric Annals · doi:10.3928/0048-5713-19890201-09 · Cited by 72
Clomipramine for panic disorder: I. the first 10 weeks of a long-term comparison with imipramine
Cassano, G., Petracca, A., Perugi, G., Nisita, C., Musetti, L., Mengali, F., & McNair, D. M. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90054-7 · Cited by 69
Zimeldine treatment of obsessive‐compulsive disorder
Kahn, R. S., Westenberg, H. G. M., & Jolles, J. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb02493.x · Cited by 67
Effects of yohimbine in obsessive compulsive disorder
Rasmussen, S. A., Goodman, W. K., Woods, S. W., Heninger, G. R., & Charney, D. S. (1987) · Psychopharmacology · doi:10.1007/bf00187248 · Cited by 65
Self-citationLactate infusions in obsessive-compulsive disorder
Gorman, J. M., Liebowitz, M. R., Fyer, A. J., Dillon, D. J., Davies, S. O., Stein, J., & Klein, D. F. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.7.864 · Cited by 64
Byerley, W., McConnell, E. J., McCabe, R. T., et al. (1988) · Psychopharmacology · doi:10.1007/bf00735896 · Cited by 61
Vogel, W., Klaiber, E. L., & Broverman, D. M. (1985) · PubMed · Cited by 60
Fluoxetine in the treatment of obsessive compulsive disorder
Fontaine, R., & Chouinard, G. (1985) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(85)90025-9 · Cited by 55
Antidepressant drugs in anxiety disorders
Modigh, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb07749.x · Cited by 54
Gately, P. F., Poon, S. L., Segal, D. S., & Geyer, M. A. (1985) · Psychopharmacology · doi:10.1007/bf00432502 · Cited by 52
Anatomical Features and Physiological Properties of Central Serotonin Neurons
Baumgarten, H. G., & Lachenmayer, L. (1985) · Pharmacopsychiatry · doi:10.1055/s-2007-1017361 · Cited by 51
Monoamine oxidase inhibitors in obsessive-compulsive disorder.
Jenike, M. A., Surman, O. S., Cassem, N. H., Zusky, P. M., & Anderson, W. H. (1983) · PubMed · Cited by 49
Laplane, D., Widlöcher, D., Pillon, B., Baulac, M., & Binoux, F. (1981) · PubMed · Cited by 46
Chlorimipramine in Obsessional States
Capstick, N. (1971) · Psychosomatics · doi:10.1016/s0033-3182(71)71497-2 · Cited by 44
A Double Blind Study of Imipramine versus Zimelidine in Treatment of Obsessive Compulsive Neurosis
Prasad, A. (1984) · Pharmacopsychiatry · doi:10.1055/s-2007-1017409 · Cited by 42
Goodman, W. K., & Charney, D. S. (1985) · PubMed · Cited by 42
Self-citationSulser, F., Gillespie, D. D., Mishra, R., & Manier, D. H. (1984) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1984.tb14500.x · Cited by 35
Effects of imipramine on depression and obsessive-compulsive symptoms
Foa, E. B., Steketee, G. S., Kozak, M. J., & Dugger, D. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90070-9 · Cited by 33
Reciprocal zones of excitation and inhibition in the neostriatum
Rebec, G. V., & Curtis, S. D. (1988) · Synapse · doi:10.1002/syn.890020609 · Cited by 31
In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat
Schmidt, C. J., & Lovenberg, W. M. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90207-1 · Cited by 30
Byerley, W., McConnel, E. J., McCabe, R. T., et al. (1987) · Brain Research · doi:10.1016/0006-8993(87)91312-6 · Cited by 28
Emrich, H. M., Berger, T., Riemann, D. W., & Zerssen, D. V. (1987) · Pharmacopsychiatry · doi:10.1055/s-2007-1017076 · Cited by 27
Zimelidine vs maprotiline in depressed outpatients A preliminary report
d'Elia, G., Hällström, T., Nyström, C., & Ottosson, J. (1981) · Acta Psychiatrica Scandinavica Supplementum · doi:10.1111/j.1600-0447.1981.tb00724.x · Cited by 21
The Importance of Brain Serotonergic Receptor Mechanisms for the Action of Antidepressant Drugs
Ögren, S. O., Fuxé, K., & Agnati, L. F. (1985) · Pharmacopsychiatry · doi:10.1055/s-2007-1017366 · Cited by 16
Yamaguchi, K., Nabeshima, T., & Kameyama, T. (1986) · PubMed · Cited by 10
Cited by
Baxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder
McDougle, C. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110037005 · Cited by 556
Eddy, K. T., Dutra, L., Bradley, R., & Westen, D. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.08.004 · Cited by 475
Stein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352
Metadata
- Authors
- Goodman, W. K.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1990-06-01
- Volume
- 47
- Issue
- 6
- Pages
- 577
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W1991750812
- Cited by
- 311
- References
- 87
- FWCI
- 23.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.